IRAK

IRAK inhibitors act on interleukin-1 receptor-associated kinases (IRAKs), kinases of innate immune receptor signaling. IRAK was cloned in 1996 as a serine/threonine kinase that associates with the interleukin-1 (IL-1) receptor after stimulation. Mice lacking IRAK4 showed severe defects in IL-1 and Toll-like receptor signaling, which established a central role for this family member. The adaptor myeloid differentiation primary response 88 (MyD88) recruits IRAK4, which then phosphorylates IRAK1 on the route to nuclear factor kappa B activation. Emavusertib, listed as CA-4948, and IRAK inhibitor 4 target IRAK4, while IRAK-1-4 Inhibitor I blocks both IRAK1 and IRAK4. The list also contains compounds with other targets, such as the c-Jun N-terminal kinase inhibitor JNK-IN-7.

7 Items

  • PROTAC IRAK4 ligand-4
    Cat. No.
    A64925

    PROTAC IRAK4 ligand-4

    PROTAC IRAK4 ligand-4 is a selective ligand that targets IRAK4, facilitating the degradation of this protein via the PROTAC (proteolysis-targeting chimera) mechanism. This compound exhibits antitumor activity, making it a valuable tool for cancer research. Additionally, it can be utilized to synthesize the PROTAC IRAK4 degrader-12, contributing to the development of targeted therapeutic strategies in oncology.

    Out of stock

    All 3 sizes
  • IRAK4 ligand-13
    Cat. No.
    A64936

    IRAK4 ligand-13

    IRAK4 ligand-13 is a selective ligand targeting IRAK4, a key component in the interleukin-1 receptor and Toll-like receptor signaling pathways. This compound is designed for the development of proteolysis-targeting chimeras (PROTACs), facilitating targeted protein degradation. It is suitable for research applications aimed at modulating immune responses and studying signaling pathways associated with inflammation and cancer.

    Out of stock

    All 3 sizes
  • IRAK4 ligand-14
    Cat. No.
    A64953

    IRAK4 ligand-14

    IRAK4 ligand-14 is a selective ligand for the interleukin-1 receptor-associated kinase 4 (IRAK4). This compound can facilitate the synthesis of proteolysis-targeting chimeras (PROTACs), including APH02174. Its application in research primarily focuses on elucidating the role of IRAK4 in immune signaling pathways and developing innovative therapeutic strategies targeting IRAK4-related diseases.

    Out of stock

    All 3 sizes
  • E3 ligase Ligand 38
    Cat. No.
    A80603

    E3 ligase Ligand 38

    E3 ligase Ligand 38 functions as an E3 ligase ligand, facilitating the development of targeted protein degraders. It is notably utilized in the synthesis of PROTAC IRAK4 degrader-12, contributing to innovative strategies in degrading specific proteins. This compound is essential for research applications focused on protein homeostasis and the modulation of intracellular signaling pathways.

    Out of stock

    All 3 sizes
  • PROTAC IRAK4 ligand-1
    Cat. No.
    A81296

    PROTAC IRAK4 ligand-1

    PROTAC IRAK4 ligand-1 is a synthetic ligand specifically designed to target interleukin-1 receptor-associated kinase 4 (IRAK4). This compound plays a critical role in the development of PROTAC IRAK4 degrader-1, facilitating targeted protein degradation. Its primary applications include cancer research and studies investigating inflammatory pathways, making it a valuable tool for researchers exploring IRAK4-related signaling mechanisms.

    5 mg
    $330.00
    10 mg
    $570.00
    All 4 sizes
  • IRAK4 ligand-12
    Cat. No.
    A81328

    IRAK4 ligand-12

    IRAK4 ligand-12 is a ligand for interleukin-1 receptor-associated kinase 4 (IRAK4), designed for use in PROTAC (proteolysis targeting chimeras) applications. This compound plays a critical role in the selective degradation of IRAK4, thus enabling the modulation of immune response pathways. It is particularly useful in research focused on inflammation and cancer, facilitating studies on targeted protein degradation strategies. IRAK4 ligand-12 can also be utilized in the synthesis of KTX-951, contributing to advancements in therapeutic development.

    Out of stock

    All 3 sizes
  • PROTAC IRAK4 ligand-5
    Cat. No.
    A81341

    PROTAC IRAK4 ligand-5

    PROTAC IRAK4 ligand-5 is a ligand designed for use in proteolysis targeting chimera (PROTAC) applications, specifically targeting IRAK4. This compound plays a crucial role in the synthesis of KT-413, facilitating the degradation of IRAK4 to modulate immune responses. It is of particular interest for research in inflammatory diseases and therapeutic development involving targeted protein degradation.

    Out of stock

    All 3 sizes

7 Items

Added to your cart

View Cart Checkout

    Loading...